ArticleProceedings of the National Academy of Sciences of the United States of America2021

Targeting OCT3 attenuates doxorubicin-induced cardiac injury.

Kevin M Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.